Deferred Income Tax Expense (Benefit) in USD of Avid Bioservices, Inc. from 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Avid Bioservices, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2019 to Q2 2024.
  • Avid Bioservices, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending July 31, 2024 was $0.000.
  • Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $114M, a 8452% increase from 2022.
  • Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $1.33M.
  • Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$115M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

Avid Bioservices, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 +$620K May 1, 2024 Jul 31, 2024 10-Q 2024-09-09
Q2 2023 -$620K -$1.18M -210% May 1, 2023 Jul 31, 2023 10-Q 2024-09-09
Q2 2022 $562K +$562K May 1, 2022 Jul 31, 2022 10-Q/A 2024-04-24
Q2 2021 $0 May 1, 2021 Jul 31, 2021 10-Q 2022-09-06

Avid Bioservices, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $114M +$112M +8452% May 1, 2023 Apr 30, 2024 10-K 2024-07-02
2022 $1.33M +$116M May 1, 2022 Apr 30, 2023 10-K 2024-07-02
2021 -$115M -$115M May 1, 2021 Apr 30, 2022 10-K 2024-07-02
2020 $0 $0 May 1, 2020 Apr 30, 2021 10-K/A 2024-04-24
2019 $0 May 1, 2019 Apr 30, 2020 10-K 2022-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.